Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_assertion type Assertion NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_head.
- NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_assertion wasGeneratedBy ECO_0000203 NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_provenance.
- NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_assertion wasDerivedFrom befree-20140225 NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_provenance.
- NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_assertion SIO_000772 21725906 NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_provenance.
- NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_assertion evidence source_evidence_literature NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_provenance.
- NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_provenance.